[1] |
Simeone A M,Broemeling L D,Rosenblum J,et al.HER-2/neu reduces the apoptotic effects of N-(4-hydroxyphenyl)retinamide(4-HPR)in breast cancer cells by decreasing nitric oxide production.Oncogene,2003,10:6739-6747.
|
[2] |
Mineta T,Rabkin S D,Yazaki T,et al.Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas.Nat Med,1995,1:938-943.
|
[3] |
Hunter W D,Martuza R L,Feiganbaum F,et al.Attenuated,replication-competent herpes simplex virus type 1 mutant G207:safety evaluation of intracerebral injection in nonhuman primates.J Virol,1999,73:6319-6326.
|
[4] |
Markert J M,Medlock M D,Rabkin S D,et al.Conditionally replicating herpes simplex virus mutant,G207 for the treatment of malignant glioma:results of a phase I trial.Gene Ther,2000,7:867-874.
|
[5] |
Varghese S,Rabkin S D.Oncolytic herpes simplex virus vectors for cancer virotherapy.Cancer Gene Ther,2002,9:967-978.
|
[6] |
Kim D,Martuza R L,Zwiebel J.Replication-selective virotherapy for cancer:Biological principles,risk management and future directions.Nat Med,2001,7:781-787.
|
[7] |
Todo T."Armed"oncolytic herpes simplex viruses for brain tumor therapy.Cell Adhesion&Migration,2008,2:208-213.
|
[8] |
Liu R,Varghese S.Rakbin S D.The treatment of C3(1)/Tag transgenic mouse breast cancer with HSV.Cancer Research,2005,64:541-549.
|
[9] |
Liu R,Martuza R L,Rakbin S D.Intracarotid delivery of G47Δto intracerebral tumors after blood brain barrier disruption.Gene Therapy,2005,12:280-288.
|
[10] |
Liu R,Rabkin S D.HSV for the treatment of human breast cancer.Chinese Medical Journal,2005,30:225-229.
|
[11] |
Cozzi P J,Malhotra S,Mc Auliffe P,et al.Intravesical oncolytic viral therapy using attenuated replication-competent herpes simplex viruses G207 and NV1020 is effective in the treatment of bladder cancer in an orthotopic syngeneic model.FASEB J,2001,15:1306-1308.
|
[12] |
Delman K A,Bennett JJ,Zager JS,et al.Effects of preexisting immunity on the response to herpes simplex-based oncolytic virus therapy.Hum Gene Ther,2000,11:2465-2472.
|
[13] |
Bennett J J,Delman K A,Burt B M,et al.Comparison of safety,delivery,and efficacy of two oncolytic herpes simplex virused(G207 and NV1020)for peritoneal cancer.Cancer Gene Ther,2002,9:935-945.
|
[14] |
Cozzi P J,Burke P B,Bhargav A,et al.Oncolytic viral gene therapy for prostate cancer using two attenuated,replicationcompetent,genetically engineered herpes simplex virus.Prostate,2002,53:95-100.
|
[15] |
Dock G.Rabies virus vaccination in a patient with cervical carcinoma.Am J Med Sci,1904,127:563.
|
[16] |
DePace N.Sulla scomparsa di un enorme cancro vegetante del collo dell'utero senza cura chirurgica.Ginecologia,1912,9:82-89.
|
[17] |
Sinkovics J,Horvath J.New developments in the virus therapy of cancer:a historical review.Intervirology,1993,36:193-214.
|
[18] |
Kirn D H.Replicating oncolytic viruses:an overview.Expert Opin Investig Drugs,1996,5:753-762.
|
[19] |
Kirn D,Niculescu Duvaz I,Hallden G,et al.The emerging fields of suicide gene therapy and virotherapy.Trends Mol Med,2002,8:S68-S73.
|
[20] |
Shen W,Wang C Y,Wang X H,et al.Oncolytic adenovirus mediated Survivin knockdown by RNA interference suppresses human colorectal carcinoma growth in vitro and in vivo.J Exp Clin Cancer Res,2009,28:81.
|
[21] |
Wodarz D,Komarova N.Towards Predictive Computational Models of Oncolytic Virus Therapy:Basis for Experimental Validation and Model Selection.PLoS ONE,2009,4:e4271.
|
[22] |
Rabkin SD,Hernaiz Driever P.Replication-competent herpes simplex virus vectors for cancer therapy.Monogr Virol Basel Karger,2001,22:1-45.
|
[23] |
Martuza R L.Conditionally replicating herpes vectors for cancer therapy.J Clin Invest,2000,105:841-846.
|
[24] |
Liu R B,Samuel D.Rabkin.Oncolytic herpes simplex virus vectors for the treatment of human breast cancer.Chinese Medical Journal,2005,118:307-312.
|
[25] |
Cornfield D B,Palazzo J P,Schwartz G F,et al.The prognostic significance of multiple morphologic features and biologic markers in ductal carcinoma in situ of the breast:a study of a large cohort of patients treated with surgery alone.Cancer,2004,100:2317-2327.
|
[26] |
邱晓光,李双兰,蒲庆田,等.端粒酶活性、c-erbB-2的表达及对乳癌早期癌变的诊断价值.中国肿瘤生物治疗杂志,2002,9:143.
|